Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures

详细信息    查看全文

• 作者：Dr. Bimal H. Ashar MD (1)
  Redonda G. Miller MD (1)
  Kelly J. Getz MA (2)
  Neil R. Powe MD ; MPH ; MBA (1) (3) (4)
  
• 关键词：pharmaceutical industry ; physician income ; clinical trials ; conflicts of interest
• 刊名：Journal of General Internal Medicine
• 出版年：2004
• 出版时间：November 2004
• 年：2004
• 卷：19
• 期：11
• 页码：1140-1145
• 全文大小：125KB
• 参考文献：1. Lamberti MJ, ed. An Industry in Evolution. 3rd ed. Boston, Mass: Centerwatch; 2001.
  2. Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342:1539鈥?4. CrossRef
  3. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. N Engl J Med. 2002;346:498鈥?05. CrossRef
  4. Moser JW. Recent developments in physician income. In: Zhang P, Thran SL, eds. Physician Socioeconomic Statistics 1999鈥?000. Chicago, Ill: American Medical Association; 1999:5鈥?4.
  5. Beran RL, Lawson GE. Medical student financial assistance, 1996鈥?997. JAMA. 1998;280:819鈥?0. CrossRef
  6. Montaner SG, O鈥橲haughnessy MV, Schechter MT. Industry-sponsored clinical research: a double-edged sword. Lancet. 2001;358:1893鈥?. CrossRef
  7. Waud DR. Gifts from industry: laundering money or supporting education? JAMA. 1994;271:505. CrossRef
  8. Chren MM, Landefeld CS, Murray TH. Doctors, drug companies, and gifts. JAMA. 1989;262:3448鈥?1. CrossRef
  9. Coyle SL. Physician-industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396鈥?02.
  10. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283:373鈥?0. CrossRef
  11. Campbell EG, Weissman JS, Clarridge B, Yucel R, Causino N, Blumenthal D. Characteristics of medical school faculty members serving on institutional review boards: results of a national survey. Acad Med. 2003;78:831鈥?. CrossRef
  12. Madhavan S, Amonkar MM, Elliott D, Burke K, Gore P. The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. J Clin Pharm Ther. 1997;22:207鈥?5. CrossRef
  13. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551鈥?. CrossRef
  14. Chren MM, Landefeld SC. Physicians鈥?behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994;271:684鈥?. CrossRef
  15. Watkins C, Harvey I, Carthy P, Moore L, Robinson E, Brawn R. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Health Care. 2003;12:29鈥?4. CrossRef
  16. Watkins C, Moore L, Harvey I, Carthy P, Robinson E, Brawn R. Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study. BMJ. 2003;326:1178鈥?. CrossRef
  17. Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996;5:201鈥?. CrossRef
  18. Gorawara-Bhat R, Gallagher TH, Levinson W. Patient-provider discussions about conflicts of interest in managed care: physicians perceptions. Am J Manag Care. 2003;9:564鈥?1.
  19. Rizzo JA, Blumenthal D. Is the target income hypothesis an economic heresy? Med Care Res Rev. 1996;53:243鈥?6. CrossRef
  20. Pham HH, Devers KJ, May J, Berenson R. Financial pressures spur physician entrepreneurialism. Health Affairs. 2004;23:70鈥?1. CrossRef
  21. American Board of Medical Specialties Statistics. 2003. Available at: http://www.abms.org/statistics.asp. Accessed March 1, 2004.
  22. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50:1129鈥?6. CrossRef
  23. Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res. 2001;35:1347鈥?5.
  24. Medical Professionalism Project. Medical professionalism in the new millennium: a physician charter. Ann Intern Med. 2002;136:243鈥?.
  25. Brett AS, Burr W, Moloo J. Are gifts for pharmaceutical companies ethically problematic? Arch Intern Med. 2003;163:2213鈥?. CrossRef
  
• 作者单位：Dr. Bimal H. Ashar MD (1)
  Redonda G. Miller MD (1)
  Kelly J. Getz MA (2)
  Neil R. Powe MD, MPH, MBA (1) (3) (4)
  
  1. the Division of General Internal Medicine, The Johns Hopkins University School of Medicine, Baltimore, Md.
  2. Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Md.
  3. Departments of Epidemiology and Health Policy and Management, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Md.
  4. Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Md.
  

文摘

BACKGROUND: The relationship between physicians and the pharmaceutical industry is controversial because of the potential for conflicts of interest. However, little empirical evidence exists on the extent of physician participation in activities sponsored by pharmaceutical companies. OBJECTIVES: To determine the prevalence of participation of internal medicine physicians in clinical trials and lectures sponsored by pharmaceutical companies and to describe factors that are associated with such participation. DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional regional survey of 1,000 Maryland internal medicine physicians between February 2000 and January 2001 in order to measure the prevalence of physician participation in pharmaceutical-sponsored clinical trials and lectures. We also collected economic and demographic information to examine potential associations between physician characteristics and engagement in such activities. RESULTS: Of 835 eligible physicians 444 (53%) responded, of whom 37% reported engaging in pharmaceutical-sponsored clinical trials and/or lectures to supplement their incomes. In our multivariable analysis, subspecialists versus generalist physicians (odds ratio [OR], 1.85; 95% confidence interval [CI], 1.14 to 2.99), physicians in private group-single specialty and academic practice versus physicians in solo practice (OR, 2.30; 95% CI, 1.19 to 4.44 and OR, 2.56; 95% CI, 1.17 to 5.61, respectively), and physicians with higher versus lower annual incomes (OR, 1.22; 95% CI, 1.04 to 1.44) had a greater odds of participation in these activities. Additionally, physicians dissatisfied with their income had a 140% greater odds of participation (OR, 2.36; 95% CI, 1.45 to 3.83) than those who were satisfied with their income. CONCLUSIONS: A substantial number of internists engage in pharmaceutical industry-sponsored clinical trials and/or lectures in an effort to supplement their incomes. Physician dissatisfaction with income appears to partially explain such participation.